Globtier Infotech IPO Subscription Status – IPO Closed

Globtier Infotech IPO subscription status started on Monday August 25, 2025 and will close on August 28, 2025. Globtier Infotech IPO to raise around ₹31.05 crores via IPO. The retail quota is 50%, and NII is 50%. The price band is fixed at ₹72 per equity share.

Table of Contents

The Globtier Infotech IPO minimum market lot is 1,600 shares with 2,30,400 application amount. The Globtier Infotech IPO is a BSE SME IPO, and it is to be listed on BSE.

Globtier Infotech Limited was founded in 2012 with the clear vision to provide IT and SAP support. Moreover, the company has also started to provide varied IT solutions with the aim of enhancing business performance via smooth workflows. Owing to strong dedication to work, along with high quality and advanced technology, over the period, the company has built a strong reputation. Additionally, the company delivered a wide range of services, given below.


IPOWatch View

We recommend investors may apply for an IPO with Neutral Views. Investors should also look at the NII, and Retail numbers before investing.

Globtier Infotech IPO Subscription Status – Day 3

CategoryDay 1Day 2Day 3
NII0.420.470.63
RII0.881.392.04
Total0.660.931.34


Globtier Infotech IPO Investor Categories

  • Qualified Institutional Buyers (QIB): Financial Institutions, Banks, FIIs, and Mutual Funds
  • Non-Institutional Investors(NII): Individual Investors, NRIs, Companies, Trusts, etc
  • Retail Individual Investors (RII): Retail Individual Investors or NRIs
  • Employee (EMP): Eligible Employees
  • Others: Eligible Shareholders

Globtier Infotech IPO Review and Rating

  • Neutral

Globtier Infotech IPO Form

How to apply for the Globtier Infotech IPO? You can apply for Globtier Infotech IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Globtier Infotech IPO in the Invest section. The other option is you can apply for Globtier Infotech IPO via IPO forms downloaded online. Check out the Asston Pharmaceuticals forms – Click IPO Forms blank IPO forms download, fill, and submit in your bank or with your broker.

Globtier Infotech IPO Subscription Status FAQs:


When Globtier Infotech IPO Subscription will start?

The IPO subscription starts on August 25, 2025 for NII, and Retail Investors.

How to subscribe Globtier Infotech IPO?

You can go with ASBA and Non-ASBA options for a subscription. Go to your bank account and apply for IPO online via ASBA or download the form online or get the physical form and submit the filled form to your broker or bank.

How do I check live Globtier Infotech IPO Subscription Numbers Today?

One can visit our portal for live IPO subscription numbers that we are updating hourly basis from the official websites. One can check the live subscription on official websites on the particular IPO page.

How to Apply the Globtier Infotech IPO through Zerodha?

Log in to Console in Zerodha Website or in Application. Go to Portfolio and Click on IPO. You will see the IPO Name “Asston Pharmaceuticals “. Click on Bid Button. Enter your UPI ID, Quantity and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Zerodha.

How to Apply the Globtier Infotech IPO through Upstox?

Log in to Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Asston Pharmaceuticals “. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Upstox.

How to Apply the Globtier Infotech IPO through Paytm Money?

Log in to Paytm Money Application with your credentials. Select the IPO. You will see the IPO Name “Asston Pharmaceuticals ” Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Paytm Money.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.